The RING finger ubiquitin ligase RNF125/TRAC-1 down-modulates HIV-1 replication in primary human peripheral blood mononuclear cells

Virology

Volumn 368, Issue 1, 2007, Pages 191-204

  Shoji Kawata, Sanae ^a   Zhong, Qiu ^b   Kameoka, Masanori ^c   Iwabu, Yukie ^a   Sapsutthipas, Sompong ^a   Luftig, Ronald B ^b   Ikuta, Kazuyoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

HIV 1; Host factor; Replication; Transcription

Indexed keywords

CD38 ANTIGEN; INTERLEUKIN 4; PROTEASOME; PROTEIN RNF125; PROTEIN TRAC 1; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

CELL LINE; GENES, REPORTER; HIV CORE PROTEIN P24; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LUCIFERASES; MUTATION; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; REPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 35348970888     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.06.028     Document Type: Article

References (56)

1. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., and Martin M.A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59 (1986) 284-291
2. Aharinejad S., Paulus P., Sioud M., Hofmann M., Zins K., Schafer R., Stanley E.R., and Abraham D. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res. 64 (2004) 5378-5384
3. Alroy I., Tuvia S., Greener T., Gordon D., Barr H.M., Taglicht D., Mandil-Levin R., Ben-Avraham D., Konforty D., Nir A., Levius O., Bicoviski V., Dori M., Cohen S., Yaar L., Erez O., Propheta-Meiran O., Koskas M., Caspi-Bachar E., Alchanati I., Sela-Brown A., Moskowitz H., Tessmer U., Schubert U., and Reiss Y. The trans-Golgi network-associated human ubiquitin-protein ligase POSH is essential for HIV type 1 production. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1478-1483
4. + T cell homeostasis and function in advanced HIV disease. Science 277 (1997) 112-116
5. Badciong J.C., and Haas A.L. MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination. J. Biol. Chem. 277 (2002) 49668-49675
6. Beauparlant P., Kwon H., Clarke M., Lin R., Sonenberg N., Wainberg M., and Hiscott J. Transdominant mutants of IκBα block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. J. Virol. 70 (1996) 5777-5785
7. Berger E.A., Murphy P.M., and Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17 (1999) 657-700
8. Bieniasz P.D., Grdina T.A., Bogerd H.P., and Cullen B.R. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7791-7796
9. Bres V., Kiernan R.E., Linares L.K., Chable-Bessia C., Plechakova O., Treand C., Emiliani S., Peloponese J.M., Jeang K.T., Coux O., Scheffner M., and Benkirane M. A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nat. Cell Biol. 5 (2003) 754-761
10. Bukovsky A.A., Song J.P., and Naldini L. Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells. J. Virol. 73 (1999) 7087-7092
11. Chen B.K., Saksela K., Andino R., and Baltimore D. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J. Virol. 68 (1994) 654-660
12. 2 hypothesis of HIV infection: new insights. Immunol. Today 15 (1994) 575-581
13. Clerici M., Hakim F.T., Venzon D.J., Blatt S., Hendrix C.W., Wynn T.A., and Shearer G.M. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91 (1993) 759-765
14. Connor R.I., Chen B.K., Choe S., and Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206 (1995) 935-944
15. Connor R.I., Sheridan K.E., Ceradini D., Choe S., and Landau N.R. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185 (1997) 621-628
16. Datta R., Imamura K., Goldman S.J., Dianoux A.C., Kufe D.W., and Sherman M.L. Functional expression of the macrophage colony-stimulating factor receptor in human THP-1 monocytic leukemia cells. Blood 79 (1992) 904-912
17. Desai S.D., Haas A.L., Wood L.M., Tsai Y.C., Pestka S., Rubin E.H., Saleem A., Nur E.K.A., and Liu L.F. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res. 66 (2006) 921-928
18. + T cells from human immunodeficiency virus-infected persons. J. Exp. Med. 182 (1995) 1759-1767
19. Fouchier R.A., Meyer B.E., Simon J.H., Fischer U., and Malim M.H. HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 16 (1997) 4531-4539
20. + lymphocytes. Nature 426 (2003) 853-857
21. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
22. + T lymphocytes to a T-tropic and a macrophage (M)-tropic human immunodeficiency virus type 1 is associated with their surface expression of CD38 molecules. Virus Res. 73 (2001) 1-16
23. + produce interleukin-4 which contributes to enhanced replication of T-tropic human immunodeficiency virus type 1. Virology 293 (2002) 94-102
24. Kameoka M., Nukuzuma S., Itaya A., Tanaka Y., Ota K., Ikuta K., and Yoshihara K. RNA interference directed against poly(ADP-ribose) polymerase 1 efficiently suppresses human immunodeficiency virus type 1 replication in human cells. J. Virol. 78 (2004) 8931-8934
25. Kawata S., Ariumi Y., and Shimotohno K. p21Waf1/Cip1/Sdi1 prevents apoptosis as well as stimulates growth in cells transformed or immortalized by human T-cell leukemia virus type 1-encoded Tax. J. Virol. 77 (2003) 7291-7299
26. 2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 11 (1997) 1111-1118
27. Korin Y.D., and Zack J.A. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol. 72 (1998) 3161-3168
28. Kurosu T., Mukai T., Komoto S., Ibrahim M.S., Li Y.G., Kobayashi T., Tsuji S., and Ikuta K. Human immunodeficiency virus type 1 subtype C exhibits higher transactivation activity of Tat than subtypes B and E. Microbiol. Immunol. 46 (2002) 787-799
29. + T-lymphocyte subset. Microbiol. Immunol. 49 (2005) 155-165
30. 1 expression in macrophages. J. Virol. 78 (2004) 8114-8119
31. + T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J. Exp. Med. 180 (1994) 489-495
32. Malavasi F., Funaro A., Roggero S., Horenstein A., Calosso L., and Mehta K. Human CD38: a glycoprotein in search of a function. Immunol. Today 15 (1994) 95-97
33. Maurice M., Verhoeyen E., Salmon P., Trono D., Russell S.J., and Cosset F.L. Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide. Blood 99 (2002) 2342-2350
34. + T-cell clones in human immunodeficiency virus infection. Blood 84 (1994) 4262-4268
35. Mizushima S., and Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18 (1990) 5322
36. Navikas V., Link J., Wahren B., Persson C., and Link H. Increased levels of IFN-γ, IL-4 and TGF-β mRNA expressing blood mononuclear cells in human HIV infection. Clin. Exp. Immunol. 96 (1994) 59-63
37. 2+-dependent manner. J. Biol. Chem. 279 (2004) 15142-15152
38. + T cell depletion in HIV-1-infected human lymphoid tissue. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 663-668
39. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70 (2001) 503-533
40. Praloran V. Structure, biosynthesis and biological roles of monocyte-macrophage colony stimulating factor (CSF-1 or M-CSF). Nouv. Rev. Fr. Hematol 33 (1991) 323-333
41. Rettenmier C.W., and Sherr C.J. The mononuclear phagocyte colony-stimulating factor (CSF-1, M-CSF). Hematol./Oncol. Clin. North Am. 3 (1989) 479-493
42. 2 responses in AIDS. Curr. Opin. Immunol. 6 (1994) 616-622
43. Savarino A., Bottarel F., Malavasi F., and Dianzani U. Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions?. AIDS 14 (2000) 1079-1089
44. Schwartz O., Marechal V., Friguet B., Arenzana-Seisdedos F., and Heard J.M. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J. Virol. 72 (1998) 3845-3850
45. Stevenson M., Stanwick T.L., Dempsey M.P., and Lamonica C.A. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9 (1990) 1551-1560
46. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., and Sodroski J. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427 (2004) 848-853
47. + T cells are infectible by human immunodeficiency virus but do not release virus after activation. J. Virol. 69 (1995) 5659-5665
48. Unutmaz D., KewalRamani V.N., Marmon S., and Littman D.R. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189 (1999) 1735-1746
49. Vigano A., Saresella M., Rusconi S., Ferrante P., and Clerici M. Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children. Highly active antiretroviral therapy. Lancet 352 (1998) 1905-1906
50. Waterman H., Levkowitz G., Alroy I., and Yarden Y. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. J. Biol. Chem. 274 (1999) 22151-22154
51. Weber B., Horiguchi J., Luebbers R., Sherman M., and Kufe D. Posttranscriptional stabilization of c-fms mRNA by a labile protein during human monocytic differentiation. Mol. Cell. Biol. 9 (1989) 769-775
52. Wei P., Garber M.E., Fang S.M., Fischer W.H., and Jones K.A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92 (1998) 451-462
53. Yamashita M., Kamitani W., Yanai H., Ohtaki N., Watanabe Y., Lee B.J., Tsuji S., Ikuta K., and Omonaga K. Persistent Borna disease virus infection confers instability of HSP70 mRNA in glial cells during heat stress. J. Virol. 79 (2005) 2033-2041
54. Yang L., Aozasa K., Oshimi K., and Takada K. Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction. Cancer Res. 64 (2004) 5332-5337
55. Zack J.A. The role of the cell cycle in HIV-1 infection. Adv. Exp. Med. Biol. 374 (1995) 27-31
56. Zhao H., Li C.C., Pardo J., Chu P.C., Liao C.X., Huang J., Dong J.G., Zhou X., Huang Q., Huang B., Bennett M.K., Molineaux S.M., Lu H., Daniel-Issakani S., Payan D.G., and Masuda E.S. A novel E3 ubiquitin ligase TRAC-1 positively regulates T cell activation. J. Immunol. 174 (2005) 5288-5297